Global Dengue Drugs Industry Supply and Demand Analysis and Development Prospect Research Report by 2022-2030


​The market report titled Global Dengue Drugs Market has been recently added by Absolute Markets Insights to its extensive repository and the data can be used to gain penetrative insights into the businesses. The case study thus addresses the present market scenario and historical developments of the market. Moreover, the case study has been gauged on the basis of primary and secondary research methodologies. Furthermore, with the help of different analysis tools such as SWOT analysis and Porter’s five analysis accurate knowledge of Global Dengue Drugs market has been presented to readers. Graphical presentation techniques such as ample graph, tables, charts, and pictures further enhances the understanding of market data. The report has been created precisely by gauging intricate market aspects and presented to readers for an effective market study.

Major players operating in the global Dengue Drugs Market: AbbVie Inc., ABIVAX, GSK group of companies, Johnson & Johnson Services, Inc., Micro Labs Ltd., Pfizer Inc., Sanofi, Sun Pharma and Takeda Pharmaceutical Company Limited

For More Information Click: https://www.absolutemarketsinsights.com/reports/Dengue-Drugs-Market-617

Additionally, the report presents extensive knowledge on distinctive market attributes such as production, revenue, and capacity. Among other distinctive features of the market report, it also includes coverage of influential market trends and of the current scenario on market shares. Significant information of the report is supported by evidence of prominent companies such as financial overview, specification and recent developments. Finally, the research also draws attention to possible strengths, weaknesses, threats, and opportunities that can affect the progress of global Dengue Drugs market.

Global Dengue Drugs Market is expected to grow at a CAGR of +2.6% from 2022 to 2030. The reported cases of dengue to World Health Organization in 2019 were 4.2 million and are spreading to multiple countries. This high number of patients has triggered numerous research and development activities for developing effective and economical dengue drugs. For instance, Indian Ministry of Science and Technology in partnership with Sun Pharmaceutical Industries Ltd. developed an herbal medicine for dengue in 2019. Similarly, 60 Degrees Pharmaceuticals of Singapore was granted a patent for a novel dengue drug named Celgosivir in 2014. These on-going developments of newer drugs are anticipated to drive the global dengue drugs market in forecast years. The maximum potential market for dengue drugs is US $338 million per year. Over 2-3 billion of the world’s population is at risk of contracting dengue.

Global Dengue Drugs Market: Report Scope
By Distribution Channel
• Hospitals
• Clinics
• Pharmacies
• Others

By Type
• Rx
• OTC

By Drug Class
• Acetaminophen
• Rehydration therapy
• Others

By Route of Administration
• Oral
• Intravenous

By Region
• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Contact Us:
Contact Name: Shreyas Tanna
Company: Absolute Markets Insights
Email Id: sales@absolutemarketsinsights.com
Phone: IN +91-7400-24-24-24, US +1-510-420-1213
Website: www.absolutemarketsinsights.co...


Comments

Post a Comment

Popular posts from this blog

Global Strategy Execution Management Solution Industry Outlook, Growth Prospects and Key Opportunities by 2030

  The global report titled as Strategy Execution Management Solution market has recently published by Absolute Markets Insights to its huge repository. This research report involves massive data which can influence the development of the Strategy Execution Management Solution market. This exploration report provides effective data which can act as a guideline for handling the risks and challenges faced in the businesses. It covers the major recent trends that are influencing the growth of the global Strategy Execution Management Solution market. Different leading players have been profiled to get a detailed description of various effective strategies carried out by top-level companies. After studying the key companies, it focuses on the startups contributing to the progress of the Strategy Execution Management Solution market. For more information about this report visit: https://www.absolutemarketsinsights.com/reports/Strategy-Execution-Management-Solution-Market-2019-2027-38...
Read more

Analyse du développement du marché mondial du suivi et de l’analyse des joueurs de sport avec prévisions jusqu’en 2030 | Amazon Web Services, Inc. Catapult, Chetu Inc., Analyse des sports de compétition – Androidfun.fr

Image
L’étude de marché mondiale Suivi et analyse des joueurs de sport est un rapport d’intelligence déclaré par Absolute Markets Insights. Les chercheurs e https://androidfun.fr/analyse-du-developpement-du-marche-mondial-du-suivi-et-de-lanalyse-des-joueurs-de-sport-avec-previsions-jusquen-2030-amazon-web-services-inc-catapult-chetu-inc-analyse-des-sports-de-competi/
Read more

Global Radiopharmaceutical Theragnostic Market Trends, Regional Segmentation, Growth Factor and Forecast from 2021 to 2030

Image
  An informative report titled as   Radiopharmaceutical Theragnostic Market   recently has been published by   Absolute Markets Insights . This measurable information offers a top to bottom investigation by thinking about a few fragments, like sort, size, innovation and applications. Diverse exploratory procedures, for example, subjective and quantitative investigation have been utilized to give information precisely. For better comprehension of the clients, it utilizes powerful graphical show procedures, like diagrams, outlines, tables just as pictures. Some of key players operating in the global radiopharmaceutical theragnostic market are Advanced Accelerator Applications, A Novartis Company, Chimeric Therapeutics Limited, Fusion Pharma, Lantheus Medical Imaging, Inc., NanoMab, NuView Life Sciences, PentixaPharm GmbH, Precirix, RadioMedix, RayzeBio, Telix Pharmaceuticals Limited, Theragnostics Ltd and Vect-Horus, amongst others. Read More on Radiopharmaceutical The...
Read more